Summit Securities Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$405K Buy
+3,800
New +$460K 0.04% 195
2026
Q1
Sell
-325
Closed -$56.6K 1207
2025
Q4
$56.6K Buy
+325
New +$59.3K 0.01% 588
2025
Q3
Sell
-2,522
Closed -$254K 1192
2025
Q2
$254K Buy
+2,522
New +$193K 0.05% 214

Other funds holding INSM

Summit Securities Group's INSM Position: Q2 2026 in Review

Summit Securities Group opened a new position in Insmed (INSM) in Q2 2026: 3,800 shares worth $405K. The stake represents 0.04% of the portfolio and ranks #195 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in INSM as recently as Q4 2025.

Summit Securities Group first reported a position in INSM in Q2 2025 and has held it in 3 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Summit Securities Group held 3,800 shares of Insmed worth $405K as of Q2 2026.
  • Insmed was a new Summit Securities Group position in Q2 2026.
  • Insmed made up 0.04% of Summit Securities Group's portfolio in Q2 2026, its #195 holding.
  • Summit Securities Group first reported a position in Insmed in Q2 2025 and has held it in 3 quarters since.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.